Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Shenlingcao Oral Liquid
DRUG
3 trials
Sponsors
West China Hospital
, Hong Kong Baptist University
Conditions
Carcinoma, Non-Small-Cell Lung
Chemotherapy, Adjuvant
Long COVID
Phase 2
The Efficacy and Safety of a Chinese Herbal Medicine for Long COVID Associated Fatigue
NCT05684952
Hong Kong Baptist University
Long COVID
Start: 2023-05-30
End: 2024-02-01
Target: 152
Updated: 2023-06-28
Phase 4
Shenlingcao Oral Liquid for Patients With Stage II or IIIA NSCLC
Completed
NCT03712969
West China Hospital
Carcinoma, Non-Small-Cell Lung, Chemotherapy, Adjuvant
Start: 2018-11-05
End: 2023-05-04
Updated: 2024-05-09
Unknown Phase
Real-World Study on Adjuvant Therapy Combined With Shenlingcao Oral Liquid in Patients for Stage II and IIIA Non-small Cell Lung Cancer After Radical Resection
Terminated
NCT03479294
West China Hospital
Carcinoma, Non-Small-Cell Lung, Chemotherapy, Adjuvant
Start: 2018-03-28
End: 2018-09-10
Updated: 2019-08-26
Related Papers
Shenlingcao oral liquid for patients with non-small cell lung cancer receiving adjuvant chemotherapy after radical resection: A multicenter randomized controlled trial.
2023-02-21
10 citations